Educational Objectives

 Discuss new clinical trial evidence on the need for aggressive control
 of lipoproteins to improve patient outcomes.

 Define mechanisms of LDL reduction.

 Discuss safety and pharmacolkinetics of pharmacologic therapy.

 Discuss updates on the vascular biology of atherosclerosis.

This edition is for information and study purposes only as the CME credits have expired.

Back to Complex Lipid Management